中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
22期
30-32,36
,共4页
张华洲%丁思勤%王铎%韦宏成
張華洲%丁思勤%王鐸%韋宏成
장화주%정사근%왕탁%위굉성
思他宁%结肠癌%肠梗阻%效果%临床意义
思他寧%結腸癌%腸梗阻%效果%臨床意義
사타저%결장암%장경조%효과%림상의의
Stilamin%Colon cancer%Intestinal obstruction%Effect%Clinical significance
目的：分析思他宁联合手术治疗结肠癌合并肠梗阻的效果和临床意义，以供参考。方法选择2011年3月~2013年2月西安医学院第二附属医院收治的结肠癌合并肠梗阻患者93例为研究对象，所有患者均接受手术治疗。根据就诊顺序奇偶数法分为对照组(n=47)和实验组(n=46)，对照组患者接受常规治疗，实验组患者在对照组治疗的基础上给予思他宁治疗。比较两组术后并发症发生情况及体液免疫水平。结果实验组患者术后并发症发生率(4.34%)明显低于对照组(17.02%)；实验组IgM、IgA、IgG水平[(1.15±0.33)、(2.28±0.45)、(8.06±1.28)g/L]均高于对照组[(0.83±0.25)、(1.56±0.31)、(7.35±1.24)g/L]，差异均有统计学意义(P<0.05)。结论思他宁联合手术治疗结肠癌合并肠梗阻可明显改善患者机体免疫功能，减少术后并发症，有利于患者的康复。
目的：分析思他寧聯閤手術治療結腸癌閤併腸梗阻的效果和臨床意義，以供參攷。方法選擇2011年3月~2013年2月西安醫學院第二附屬醫院收治的結腸癌閤併腸梗阻患者93例為研究對象，所有患者均接受手術治療。根據就診順序奇偶數法分為對照組(n=47)和實驗組(n=46)，對照組患者接受常規治療，實驗組患者在對照組治療的基礎上給予思他寧治療。比較兩組術後併髮癥髮生情況及體液免疫水平。結果實驗組患者術後併髮癥髮生率(4.34%)明顯低于對照組(17.02%)；實驗組IgM、IgA、IgG水平[(1.15±0.33)、(2.28±0.45)、(8.06±1.28)g/L]均高于對照組[(0.83±0.25)、(1.56±0.31)、(7.35±1.24)g/L]，差異均有統計學意義(P<0.05)。結論思他寧聯閤手術治療結腸癌閤併腸梗阻可明顯改善患者機體免疫功能，減少術後併髮癥，有利于患者的康複。
목적：분석사타저연합수술치료결장암합병장경조적효과화림상의의，이공삼고。방법선택2011년3월~2013년2월서안의학원제이부속의원수치적결장암합병장경조환자93례위연구대상，소유환자균접수수술치료。근거취진순서기우수법분위대조조(n=47)화실험조(n=46)，대조조환자접수상규치료，실험조환자재대조조치료적기출상급여사타저치료。비교량조술후병발증발생정황급체액면역수평。결과실험조환자술후병발증발생솔(4.34%)명현저우대조조(17.02%)；실험조IgM、IgA、IgG수평[(1.15±0.33)、(2.28±0.45)、(8.06±1.28)g/L]균고우대조조[(0.83±0.25)、(1.56±0.31)、(7.35±1.24)g/L]，차이균유통계학의의(P<0.05)。결론사타저연합수술치료결장암합병장경조가명현개선환자궤체면역공능，감소술후병발증，유리우환자적강복。
Objective To analyze the effects and clinical significance of Stilamin and operation in the treatment of colon cancer and intestinal obstruction, and offer the reference. Methods 93 patients with colon cancer and intestinal obstruction from March 2011 to February 2013 in the Second Affiliated Hospital of Xi'an Medical College were select-ed as study objects, and all patients were treated with operation, they were divided into control group (n=47) and ex-perimental group (n=46) according to visiting sequence of odd and even number method, patients in the control group were received the routine treatment, patients in the experimental group were treated with Stilamin on the basis of the reatment of the control group. The postoperative complications and humoral immunity of the two groups were compared. Results The rate of complication in the control group (17.02%) was lower than that of the experimental group (4.34%);the levels of IgM, IgA, IgG in the experimental group [(1.15±0.33), (2.28±0.45), (8.06±1.28) g/L] were higher than those of the control group [(0.83±0.25), (1.56±0.31), (7.35±1.24) g/L], the differences were statistically significant (all P <0.05). Conclusion Stilamin combined with operation can significantly improve the immune function of patients with colon cancer and intestinal obstruction, reduce the postoperative complications, and it is conducive to the rehabilitation.
